There are 2789 resources available
1328P - Outcomes from local consolidative therapy and immune checkpoint inhibitors in metastatic non-small cell lung cancer
Presenter: Lingzhi Hong
Session: ePoster Display
1329P - A single-arm, open-label, multi-center, phase I study of HA121-28 in patients with advanced solid tumors
Presenter: Hongyun Zhao
Session: ePoster Display
1330P - Second-line nintedanib + docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: Updated efficacy and safety results from VARGADO Cohort C
Presenter: Christian Grohé
Session: ePoster Display
1331P - Open-label phase I/II study evaluating the tolerability and anti-tumor activity of selinexor (SEL) and docetaxel (DTX) in non-small cell lung cancer (NSCLC)
Presenter: Alona Zer
Session: ePoster Display
1332P - A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)
Presenter: Susumu Takeuchi
Session: ePoster Display
1445P - Zoledronic acid quarterly versus monthly conventional schedule in patients with solid tumors with bone metastases
Presenter: Vitor Liutti
Session: ePoster Display
1446P - Weekly hypofractionated palliative radiotherapy in poor performance status and elderly patients unfit for standard radiotherapy: Survival, acute and late toxicity outcomes
Presenter: Carlo Soatti
Session: ePoster Display
1447P - Efficacy and toxicity profile of trans dermal buprenorphine for cancer pain management: Experience from a tertiary care center in northern India
Presenter: Varun Goel
Session: ePoster Display
1448P - Palliative care for cancer patients: A survey on the opinion and concerns of medical oncologists in Greece
Presenter: Maria Paraskeva
Session: ePoster Display